Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus …
Background—In the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI
2D) trial, an initial strategy of coronary revascularization and optimal medical treatment …
2D) trial, an initial strategy of coronary revascularization and optimal medical treatment …
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI …
MM Brooks, BR Chaitman, RW Nesto, RM Hardison… - Circulation, 2012 - Am Heart Assoc
Background—The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI
2D) trial assigned patients with type 2 diabetes mellitus to prompt coronary revascularization …
2D) trial assigned patients with type 2 diabetes mellitus to prompt coronary revascularization …
Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: results from the Bypass Angioplasty …
L Schwartz, M Bertolet, F Feit, F Fuentes… - Circulation …, 2012 - Am Heart Assoc
Background—Patients with diabetes have more extensive coronary disease than those
without diabetes, resulting in more challenging percutaneous coronary intervention or …
without diabetes, resulting in more challenging percutaneous coronary intervention or …
The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic …
BR Chaitman, RM Hardison, D Adler, S Gebhart… - Circulation, 2009 - Am Heart Assoc
Background—The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI
2D) trial in 2368 patients with stable ischemic heart disease assigned before randomization …
2D) trial in 2368 patients with stable ischemic heart disease assigned before randomization …
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D …
BARI 2D Study Group - American Heart Journal, 2008 - Elsevier
BACKGROUND: The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI
2D) trial was undertaken to determine whether early revascularization intervention is …
2D) trial was undertaken to determine whether early revascularization intervention is …
Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes …
BE Sobel, R Frye, KM Detre - Circulation, 2003 - Am Heart Assoc
A paradoxical increase in mortality attributable to diabetes has occurred, particularly during
the last decade, despite the overall decrease in mortality attributable to coronary artery …
the last decade, despite the overall decrease in mortality attributable to coronary artery …
The Coronary ArteryRevascularisation in Diabetes (CARDia) trial: Background, aims, and design
A Kapur, IS Malik, JP Bagger, JR Anderson… - American heart …, 2005 - Elsevier
BACKGROUND: Patients with diabetes have an increased incidence and severity of
ischemic heart disease, which leads to an increased requirement for coronary …
ischemic heart disease, which leads to an increased requirement for coronary …
Medical treatment and revascularization options in patients with type 2 diabetes and coronary disease
GBJ Mancini, ME Farkouh, MM Brooks… - Journal of the American …, 2016 - jacc.org
Background: There are scant outcomes data in patients with type 2 diabetes and stable
coronary artery disease (CAD) stratified by detailed angiographic burden of CAD or left …
coronary artery disease (CAD) stratified by detailed angiographic burden of CAD or left …
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery …
GR Dagenais, J Lu, DP Faxon, P Bogaty… - Journal of the American …, 2013 - jacc.org
Objectives: The purpose of this analysis was to assess in patients with type 2 diabetes and
stable coronary artery disease (CAD) whether the risk of all-cause mortality and …
stable coronary artery disease (CAD) whether the risk of all-cause mortality and …
Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 …
MA Hlatky, DB Boothroyd, KA Melsop, L Kennedy… - Circulation, 2009 - Am Heart Assoc
Background—The economic outcomes of clinical management strategies are important in
assessing their value to patients. Methods and Results—Bypass Angioplasty …
assessing their value to patients. Methods and Results—Bypass Angioplasty …